Placeholder

FACULTY

Paula Seal

Associate Professor - Clinical

Medicine - Infectious disease

Academic Office:

LSUHSC School of Medicine 
1542 Tulane Avenue, Suite 331, Box  T4M-2,
New Orleans, LA 70112

504-568-5031

 

Clinical Office:

University Medical Center, Ambulatory Care Building
2000 Canal St, 
New Orleans, LA 70112

504-702-4344

 

Bio

Paula S. Seal, MD, MPH, is the Associate Program Director of  the Infectious Diseases Fellowship Program. She completed her Masters in Public Health at the Ryals School of Public Health at UAB. She subsequently attended Medical School at Louisiana State University New Orleans and completed her Residency and Fellowship at the University of Alabama at Birmingham. Her clinical practice is focused on HIV outpatient clinical care at the LSU HIV Outpatient Clinic at the University Medical Center New Orleans. Her quality improvement interests include HIV engagement and retention in care as well as community uptake in PrEP.

Education

Undergraduate:
1997 - B.S.
University of the South
Sewanee, Tennesse

Graduate:
2001 - Master of Public Health
UAB Ryals School of Public Health
Birmingham, Alabama

Medical:
2005 - M.D.
Louisiana State University School of Medicine
New Orleans, Louisiana

Internship:
2006 - Internal Medicine
University of Alabama Birmingham
Birmingham, Alabama

Residency:
2008 - Internal Medicine
University of Alabama Birmingham
Birmingham, Alabama

Fellowship:
2010 - Infectious Diseases
University of Alabama Birmingham
Birmingham, Alabama

Affiliated Hospitals & Clinics

University Medical Center, Infectious Disease Clinic

Publications

1. 2020, Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients with COVID-19 in a New Orleans Cohort.  Open Forum Infect Dis. 2020 Aug 13; 7(9).  doi: 10.1093/ofid/ofaa339

2. 2018, Intracranial Hypertension secondary to Eosinophilic Meningitis caused by Angiostronylus cantonensis.  Journal of the Louisiana State Medical Society. 170 May/June (83-87); 2018.

3. 2017, Early HIV Diagnosis Leads to Significantly Decreased Costs in the First 2 Years of HIV Care in an Urban Charity Hospital in New Orleans. J Int Assoc Provid AIDS Care. 2017 Nov/Dec; 16 (6):527-530.  doi:  10.1177/2325957417737381.

4. 2016, Characteristics and genotype profiles of antiretroviral-naive patients entering a Southern US HIV outpatient clinic 2009-2012. Int J STD AIDS. 2016 Jun; 27(7):554-559.  doi: 10.1177/0956462415588654.

5. 2015. Predictors of renal dysfunction among diabetic HIV+ patients. HIV Clinician. 2015 Summer; 27 (3):8-9.

6. 2014.Clinical Case of the month: A 22 year old man with AIDS presenting with shortness of breath and an oral lesion. J La State Med Soc. 2014 Sept-Oct; 166 (5):224-230. PMID: 25369228

7. 2014, Challenges in the management of chronic pain in HIV/AIDS. HIV Clinic. 2014; 26(2):12-15. PMID: 25151677

8. 2014, From diagnosis to engagement in HIV care: Assessment and predictors of linkage and retention in care among patients diagnosed by emergency department-based testing in an urban public hospital.  AIDS  Patient Care STDS. 2014 Jun; 28(6): 277-279. doi: 10.1089/apc.2014.0052.

9. 2014, HIV prevalence of inappropriate urine drug tests in a pain clinic for patients with HIV.  Pain Med.  2014 Jun; 15(6): 1058-1059. doi: 10.1111/pme.12369.

10. 2013, Clinical Case of the month. A 50 year old man with a persistent rash.  J La State Med Soc.  2013 Jan-Feb; 165(1): 46-48, 51-52, 55. PMID: 23550399.

11. 2012, Sexual health knowledge of male and female Latino immigrants.  J Immigrant and Minority Health.  2012  Aug; 14(4): 673-681. doi: 10.1007/s10903-012-9576-8.

12. 2012, HIV-infected women’s relationships with their healthcare providers in the rural Deep South: An exploratory study.  Health Care Women Int.  2012; 33(4): 403-419. doi: 10.1080/07399332.2011.610533.

13. 2011, Temporal trends in late presentation for outpatient HIV medical care 2000-2010:  Implications for short-term  mortality.  J Gen Int Med.  2011 Jul; 26(7): 745-750. doi: 10.1007/s11606-011-1693-x.

14. 2010, Perceived barriers to HIV care among HIV-infected  women in the Deep South.  J Assoc Nurses AIDS Care.   2010 Nov-Dec; 21(6): 467-477. doi: 10.1016/j.jana.2010.03.003.

15. 2010, A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern U.S.: Implications for targeted interventions.  AIDS Patient Care STDS.  2010 Aug; 24(8): 515-520. doi: 10.1089/apc.2010.0065.

16. 2006, Sociodemographic and environmental predictors of childhood stunting in rural Guatemala.  Nutrition Res.  2006; 26(2): 65-70.

Research

Title: Utilization of serum hyaluronic acid as a predictive tool for HIV-associated cancer risk in minority patients
Location: UAB Center for Clinical and Translational Science
Dates: 2012-2013

Title: WAVES Study: Women's Antiretroviral Efficacy and Safety: A Randomized Double-Blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disporoxil Fumarate in HIV-1 infected, Antiretroviral-Naive Women
Sponsor: Gilead GU-US-236-0128
Dates: 2013-2015

Title: Risks, Practices, Perceptions and Linkage to Care in MSMs in Rural Louisiana. 
Location: Tulane University
Dates: 2014-2015

Title: The STRIVING Study: A Phase IIIb, Randomized, Open-Label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-Dose Combination of Abacavir/Dolutegravir/Lamivudine from Current Antiretroviral Regimen Compared with Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed.
Sponsor: GSK 201147
Dates: 2015